These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7298009)

  • 1. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis.
    Fallucca F; Ziparo V; Giangrande L; Menzinger G; Stipa S
    Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
    Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
    Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pancreatic polypeptide and glucagon immunoreactivity in fasting healthy and diabetic children.
    Walczak M; Mrozikiewicz D; Dmochowski K; Rewers M; Cichy W
    Mater Med Pol; 1989; 21(1):38-42. PubMed ID: 2699344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes.
    Lugari R; Dell'Anna C; Ugolotti D; Dei Cas A; Barilli AL; Zandomeneghi R; Marani B; Iotti M; Orlandini A; Gnudi A
    Horm Metab Res; 2000 Oct; 32(10):424-8. PubMed ID: 11069208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon secretion in subjects with prediabetes, diabetes mellitus and obesity.
    Slavnov VN; Epshtein EV; Efimov AS; Malinkovich VD; Stepanenko LI
    Endocrinologie; 1979; 17(3):213-8. PubMed ID: 504963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
    Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
    J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of plasma glucagon to the hyperglycaemia and hyperinsulinaemia of surgical operation.
    Giddings AE; O'Connor KJ; Rowlands BJ; Mangnall D; Clark RG
    Br J Surg; 1976 Aug; 63(8):612-6. PubMed ID: 953465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
    Dupre J; Caussignac Y; McDonald TJ; Van Vliet S
    J Clin Endocrinol Metab; 1991 Jan; 72(1):125-9. PubMed ID: 1986010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes.
    Lawecki J; Symonides-Lawecka A; Rogala H
    Pol Med Sci Hist Bull (1973); 1976; 15(2):177-82. PubMed ID: 959042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired alpha cell function in conditions with cortisol deficiency.
    Fallucca F; Gambardella S; Tamburrano G; Spallone V; Napoli A; Menzinger G
    J Endocrinol Invest; 1980; 3(3):263-5. PubMed ID: 7000877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.